Unlocking opioid neuropeptide dynamics with genetically encoded biosensors.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neuropeptides are crucial signaling molecules in the nervous system, but studying their dynamics is challenging.
• Opioid peptides are particularly relevant for pain, reward, and aversion, yet precise circuit-level analysis is limited.
• Existing experimental tools lack the specificity to dissect complex neuropeptide signaling dynamics.

Purpose of the Study:

• To develop genetically encoded fluorescence sensors for visualizing endogenous opioid signaling.
• To characterize the spatiotemporal dynamics of opioid peptides in specific neural circuits.
• To enable precise dissection of opioid receptor activity in response to physiological and optogenetic stimuli.

Main Methods:

• Development of kappa, delta, and mu opioid receptor-based fluorescence sensors (κLight, δLight, µLight).
• Pharmacological characterization of sensors in mammalian cells and dissociated neurons.
• Application of sensors in brain slices and in vivo fiber photometry in mice for measuring endogenous opioid release.

Main Results:

• Successfully developed and characterized κLight, δLight, and µLight sensors.
• Identified parameters for triggering endogenous opioid release and mapped dynorphin transmission in brain slices.
• Demonstrated in vivo detection of optogenetically induced opioid release and observed differential opioid dynamics in fear and reward states.

Conclusions:

• The developed light-activated sensors provide unprecedented tools for studying endogenous opioid signaling.
• These sensors allow for circuit-specific and spatiotemporal analysis of opioid dynamics in the brain.
• The findings offer new avenues for understanding the role of opioids in complex behaviors and for developing targeted therapeutics.